- Research article
- Open Access
Evaluation of anticancer properties of a decoction containing Adenanthera pavonina L. and Thespesia populnea L.
BMC Complementary and Alternative Medicine volume 16, Article number: 70 (2016)
A decoction composed of Adenanthera pavonina L. and Thespesia populnea L. is currently being used in the treatment of cancer patients.
Lactate Dehydrogenase (LDH) release, (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) MTT, and Sulforhodamine B (SRB) assays were carried out to study cytotoxicity and anti-proliferative activity against the HEp-2 cells, 24 h post-treatment with the decoction.
The mean (± SD) values of EC50 were 195.50 (±40.68), 120.02 (±29.82) and 77.06 (±8.80) μg/ml for LDH, MTT, and SRB assays respectively. These results strongly correlate the morphological changes observed in cells treated with the decoction. Induction of apoptosis was visualized by fluorescence microscopy stained with ethidium bromide/acridine orange dye mix. In addition, brine shrimp lethality assay showed an EC50 value at a higher concentration (1.96 mg/mL).
These results suggest that the decoction prepared with Adenanthera pavonina L. and Thespesia populnea L. exhibits anti-proliferative activity and induces apoptosis on the HEp-2 cancer cells but no toxicity against Artemia salina.
Cancer has been an important issue in medicine as it is one of the major causes of death in both the developed and developing countries and is now recognised only to be secondary to myocardial infarction . The discovery of novel anticancer therapeutics from natural sources, mainly from plants of medicinal value remains pivotal. Firstly, the broad spectrum of inherent toxicities associated with contemporary anticancer agents and secondly the acquired resistance to currently available drugs warrants cancer researchers to explore further, the ability of natural products to engage as potential anticancer agents . Traditional medical practitioners have been using crude drug extracts and biologically active compounds, isolated from plant species for a number of years. Some of the prescriptions used in Sri Lanka have been studied for anticancer activity in vitro using cancer cell lines [3, 4]. In our study, we are evaluating the anticancer properties of a complete decoction currently used to cure chronic cancer patients. The decoction used in the present study contains Adenanthera pavonina L. and Thespesia populnea L. Both of these plants have numerous medicinal applications. Some of them include the anti-diabetic, anti-hyperlipidemic activity , antinociceptive, anti-inflammatory effects , antibacterial activity  and pharmacological effects related to Alzheimer’s disease  by Thespesia populnea L. Similarly, Adenanthera pavonina L. contains anti-inflammatory [9, 10], anti-bacterial , anti-hyperglycemic, lipid reducing potential  antioxidant and cytotoxicity properties . A decoction prepared in combination with these two plants, Adenanthera pavonina L. and Thespesia populnea L. has been used for years to cure cancer patients by indigenous practitioners. A previous study carried out in our laboratory has shown that the same decoction possesses strong antioxidant activity in vitro . Hence, the present study was carried out to evaluate the scientific validity of the decoction on anticancer properties.
Materials and equipment
Chemicals were purchased from Sigma Chemicals Co. (P.O. Box 14508, St. Louis, MO 63178 USA) and Fluka (Flukachemie GmbH, CH-9471 Buchs). Lactate Dehydrogenase (LDH) enzyme assay kits were purchased from Roche (Roche Diagnostics GmbH, Germany) and Randox (Randox Laboratories Ltd., Crumlin Co. Antrim, UK). All chemicals used were of analytical grade. The decoction was freeze dried using LFT 600EC freeze dryer equipped with an external pump (Hitachi, Japan). SHIMADZU UV 1601 UV- Visible spectrophotometer (Shimadzu Corporation, Kyoto, Japan) was used to read the absorbance. Cells were observed using Olympus (1X70-S1F2) inverted fluorescence microscope (Olympus Optical Co. Ltd. Japan), and Nikon D700 (105 mm macro lens, film speed 1000 asa, Japan) was used to capture the photographs. Deionised water used in all experiments was obtained from LABCONCO (waterproplus) UV ultra-filtered water system (LABCONCO Corporation, Kansas city, Missouri 64132–2696).
Plant materials and preparation of the decoction
The phytochemical composition of this decoction was previously determined by our laboratory . The mean ± SD of the total phenols and flavonoids were determined to be 34.14 ± 3.54 w/w % gallic acid equivalents and 42.40 ± 0.39 w/w % EGCG equivalents respectively. The presence of these phytochemicals may contribute to the apoptotic effects observed. To prepare the decoction, the barks of Thespesia populnea L. (Indian tulip tree/Pacific rosewood/Bebaru/Gansuriya) were collected from live plants in Deniyaya (Matara District) and the barks of Adenanthera pavonina L. (Red bead tree/Coral tree/Red Sandalwood tree /Madatiya) were obtained from Kotte, Colombo district, Sri Lanka . All plant materials were identified and confirmed by the Department of Botany, Bandaranayake Memorial Ayurveda Research Institute, Nawinna, Colombo, Sri Lanka and voucher specimens are available at the same premises. The barks of Thespesia populnea L. (30 g) and Adenanthera pavonina L. (30 g) were used in equal proportion to prepare the decoction. The recipe for decoction was provided by Dr. Nimal Jayathilake, Consultant Physician, Bandaranayake Ayurvedic Research Institute, Nawinna, Maharagama. All the plant ingredients were made into smaller pieces and a fine powder was obtained using a clean kitchen blender. The contents were then boiled with 1.6 L of water in a clay pot with a lid. Boiling was allowed to continue until the volume decreased to 200 ml (1/8th of the original volume). The aqueous extracts were subsequently decanted and filtered through a piece of clean cheese cloth (Vijay Auction, Colombo, Sri Lanka). The extract was then centrifuged at 1000 rpm for 5 min. The supernatant was retained and the pellet was solubilised with a minimum quantity of deionised water, sonicated and centrifuged at 2500 rpm for 8 min. Both supernatants were pooled and then freeze dried. The freeze dried samples were stored at −20 °C in sterile tubes until further use. Three individually prepared decoctions were made according to the above procedure.
HEp-2 cell line originally obtained from Medical Research Institute, Sri Lanka, which was preserved and maintained in the Department of Biochemistry and Molecular Biology, was used for all cytotoxic experiments.
Cell culture and preparation of the cells for cytotoxicity
Cells were cultured in Eagle’s Minimum Essential Medium (EMEM) supplemented with 10 % fetal bovine serum (FBS), MEM non-essential (1 %), L-glutamine (3 %), 50 IU/ml penicillin and 50 μg/ml streptomycin. The pH of the growth media were adjusted to physiological pH (7.4) using 7.7 % sodium bicarbonate. Cells were maintained at 37 °C in a 5 % carbon dioxide (CO2). The cells were seeded in a 24-well plate (2 × 105) and cultured overnight. Confluent monolayer was treated with different concentrations of the decoction at 37 °C for 24 h in humidified CO2 incubator. In all experiments, a negative control without the decoction and a positive control with camptothecin (5 mM) were used.
MTT (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is a semi-automated colorimetric assay based on the principle that the mitochondria of live cells reduce the tetrazolium salt, MTT to blue formazan compounds . The cells were cultured overnight on 24-well plates as described above and treated with different concentrations (50–500 μg/ml) of the decoction for 24 h at 37 °C in a humidified CO2 incubator. The negative control without the plant extract was used and the final volume of each well was adjusted to 1 ml with growth media. After 24 h, the supernatant was subsequently replaced with regular media (1 ml) followed by the addition of MTT (5 mg/ml in PBS). The cells were incubated at 37 °C for 4 h and the media was carefully removed. The formazan crystals were then dissolved in acidified isopropanol (0.05 M HCl in IPA) by mixing well with pipette tip. The absorbance of the resulting solution was measured at 570 nm. Acidified IPA was used to zero the spectrophotometer. The percentage viability was calculated as given below:
The net absorbance from the wells of untreated cells was taken as 100 % viable. The experiment was carried out in triplicates.
Lactate dehydrogenase (LDH) activity
The changes in the membrane permeability can be detected by the leakage of enzymes such as lactate dehydrogenase. The cells were treated with the decoction at different concentrations (50 – 500 μg/ml) for 24 h. The culture supernatants (200 μl) and cell lysates (200 μl) were tested for the presence of LDH enzyme, using the LDH detection kit.
The experiment was performed in triplicates.
Sulforhodamine B assay
The Sulforhodamine B (SRB) assay, first described by Skehan and colleagues (1990) is based on the ability of the SRB dye to bind electrostatically to the basic amino acid residues . The monolayer of cells was treated at different concentrations (40–160 μg/ml) of the decoction and cultured overnight in a humidified CO2 incubator. The medium was then removed completely. The adherent cells were treated with trichloroacetic acid (10 %; 500 μl) to fix the cellular protein and the plate was incubated at 4 °C for at least 1 h prior to the SRB assay. The plate was then washed with five washing cycles using deionised water and dried completely. A volume of 500 μl of SRB (0.4 %; in 1 % acetic acid) was added to each well and allowed to stain for 30 min. The excess stain was removed and the plate was subjected to five washing cycles again to remove unbound dye using 1 % acetic acid (vol/vol). After air-drying, the protein bound dye was solubilised with Tris base (10 mM; 500 μl) and the plates were shaken for at least 30 min. The absorbance was then recorded at 564 nm using Tris base as blank. The percentage viability was calculated as given below:
The experiment was carried out in triplicates.
Cells (2 × 105 cells per well), were seeded in 24-well plates and exposed to the decoction at two different concentrations (50 and 100 μg/ml) for 24 h as described earlier. The morphological changes of cells were observed using Olympus (1X70-S1F2) inverted fluorescence microscope at 100X magnification and photographed using Nikon D700 camera. A negative control (untreated cells) and a positive control (Camptothecin: 5 mM) were also analysed for comparison.
Ethidium Bromide/Acridine Orange Staining (EB/AO staining)
Differential uptake of dyes that bind to DNA is technique that is used to determine the mode of cell death, especially the difference between apoptosis and necrosis . Most of the live cells are permeable to acridine orange (AO) and hence the nuclei of AO-stained cells appear green. In contrary, ethidium bromide (EB), which stains red, enters the cell only when there is a loss in the cell membrane integrity. Thus live cells exhibit green nuclei, early apoptotic cells bright green nuclei with fragmented chromatin and late apoptotic cells have condensed and fragmented orange chromatin. However, the necrotic cells will possess a normal orange/red nucleus with no aberrant changes .
Induction of apoptosis by the decoction was investigated with AO/EB dye staining as described by Ribble et al. . The cells (2 × 105) were treated with two different concentrations (50 and 150 μg/ml) of the decoction and cultured overnight in a humidified CO2 incubator at 37 °C. The media was transferred to 15 ml tubes. The rest of the adherent cells were detached with Trypsin-EDTA (1 ml) and incubated at 37 °C for 2 min. The media and the detached cells from the same sample were pooled together and centrifuged at 1,000 rpm for 5 min. Cell pellets were then re-suspended in 25 μl cold PBS and 2 μl EB/AO dye mix (EB/AO dye mix contained 100 μg/ml of each dye). Stained cell suspensions (10 μl) were visualized using an Olympus (1X70-S1F2) inverted fluorescence microscope at 100X magnification and photographed using Nikon D700 camera.
Brine shrimp lethality assay
Brine shrimp lethality bioassay was carried out to investigate the general cytotoxicity of the decoction . Brine shrimps (Artemia salina) were hatched using brine shrimp eggs in a petri dish (diameter – 85 mm) filled with 12 ml of filter-sterilized sea water (pH 8.5) for a period of 24 h under aeration. Ten nauplii were drawn through a pipette and placed in 24-well plates (final volume 2 ml) at different concentrations of the decoction. The plate was maintained at room temperature for 24 h under aeration and the surviving larvae were counted. Experiments were conducted along with a negative control. The percentage lethality was calculated from the mean survival larvae of extracts treated with the decoction and control. The experiment was carried out in triplicates.
Calculations and statistics
A minimum of three independent experiments were carried out unless otherwise specified. Linear regression analysis were carried out using Microsoft Excel. Calibration curves of the standards were considered as linear if R2 > 0.99. Linear segment of the sigmoid curves of the dose response curves between percentage cell viability and log concentration were used to determine the EC50 values.
The cell viability was determined by MTT reduction assay after 24 h treatment with decoction as described earlier. A dose–response curve for the percentage of viable cells was plotted against concentrations of the extract. Maximum growth inhibition was shown at concentrations over 300 μg/ml, however, the cell viability remained unchanged and the decoction was not effective in cytotoxicity at concentrations <80 μg/ml. The EC50 value obtained was 120.02 ± 29.82 μg/ml (Fig. 1a).
LDH release into the medium and subsequent reduction in NADH concentration was used as an index of the integrity of cell membranes and on this basis, percentage LDH released was calculated as described previously. A dose dependent increase of LDH release was observed with the decoction with an EC50 value of 195.50 ± 40.68 μg/ml (Fig. 1b). A maximum inhibition of 80 % was observed at concentrations over 350 μg/ml of the decoction. The LDH release for negative and camptothecin (positive control) were 21 and 41 % respectively.
Sulforhodamine B (SRB) assay
The effect of the decoction on HEp-2 cell survival was determined by the SRB assay as previously described. A dose-dependent inhibition was observed with an inhibition of 78.54 % at concentration of 160 μg/ml. The EC50 value for the decoction was observed at 77.06 ± 8.80 μg/ml (Fig. 1c).
Cell morphology studies and Ethidium Bromide/Acridine Orange Staining (EB/AO staining)
The cytotoxic effects of the decoction on HEp-2 cells were analyzed using an inverted fluorescence microscope as depicted in the Fig. 2, top panel. The figures show the potential of the decoction in inducing apoptosis in the HEp-2 cells by demonstrating the morphological changes characteristic to apoptosis such as membrane blebbing, cell shrinkage, nuclear and cytoplasmic condensation and formation of apoptotic bodies as compared to the negative control. Apoptotic and necrotic cells were further investigated using fluorescence microscopy and double staining with ethidium bromide and acridine orange (Fig. 2-bottom panel). Live cells displayed a uniformly green fluorescence which had regular, round-shaped nuclei in the absence of decoction (Fig. 2e). The early apoptotic cells were observed at a concentration of 50 μg/ml, which the cells were still green in color with bright green dots in their nuclei corresponding to nuclear fragmentation (Fig. 2f). The late apoptotic cells were visible at concentration of 150 μg/ml of the decoction and in positive control, camptothecin (5 mM) which had stained orange attributed to incorporation of both ethidium bromide and acridine orange (Fig. 2g & h).
Brine shrimp lethality assay
Brine shrimp lethality is the simplest bioassay useful for screening large number of extracts in the drug discovery process. Preliminary experiments carried out at a concentration range of 50 – 800 μg/ml did not show any toxic effect on brine shrimp assay. However, the number of live brine shrimps decreased with a concentration >1.5 mg/ml with an EC50 of 1.96 ± 44.84 mg/ml (Fig. 3).
Complementary and alternative medicine (CAM) is very popular in the contemporary world and is widely adopted around the globe . A decoction, containing barks of Thespesia populnea and Adenanthera pavonina is used in the treatment of cancer by traditional physicians in Sri Lanka. Lyophilized samples of this extract were studied for its phenolic and antioxidant activity and the findings were previously published . The results of this initial study clearly demonstrated that the potent antioxidant activity of the decoction is justified by its high phenolic constituents and flavonoids. Therefore, we initiated to evaluate the cytotoxic properties using a range of assays to provide evidence of potent anticancer abilities of the decoction.
In this study, the anti-proliferation and induction of apoptosis by the decoction were studied using MTT, LDH and SRB assays with HEp-2 cell line. It was found that the decoction significantly inhibited the proliferation of HEp-2 cells after incubation of the cells for a period of 24 h and the results showed a concentration-dependent decrease in the percentage cell viability of the HEp-2 cell line.
The observation of apoptotic cells at higher concentrations suggest that the effect of the decoction is cytocidal at least at higher concentrations. We also feel that the cytocidal or cytostatic phenotype mostly depends on the concentration used and the incubation time. When we use a concentration close to the EC50 of the drug (150 μg/ml), the apoptotic signal appears to be stronger that when the concentration of the decoction was used three times lesser than the EC50 (50 μg/ml), suggesting that the effect of the decoction was dose-dependent. The two concentrations of the decoction, we have included in the manuscript, provides two clear phenotypes of early and late apoptosis incurred by the decoction.
Previous studies conducted by Boonsri et al. (2008) evaluated the cytotoxic properties of Thespesia populnea . In their study, the heartwood and wood were separately extracted from T. populnea in dichloromethane and these extracts were shown to induce a potent cytotoxic ability against different cancer cell lines, including MCF-7, HeLa, HT-29, and KB cells. In addition, Johnson et al. (1999) extracted four quinones, namely mansonone-D, mansonone-H, thespone and thespesone from the heartwood of T. Populnea and evaluated their cytotoxicity in MCF-7 breast cancer cells . Mansonone-D and Thespone showed enhanced cytotoxic effects than the other two quinones, mainly owing to generation of superoxide anions, which the authors speculate to be responsible for the cell killing effect. Masuda et al. (2002) evaluated the cytotoxic activity of leaf extracts in sea shore plants in the subtropical regions of Japan via flow cytometry using ethidium bromide and annexin V-FITC as fluorescent probes. One of these plants was T. Populnea and the leaf extracts exhibited potent cytotoxic effect against human leukemic cell line, K562 . It is interesting to observe the presence of several natural occurring cytotoxic compounds in T. populnea and one of compounds, most elaborately studied is Gossypol . Gossypol is present usually in members of the Malvaceae family, including cotton plant (Gossypium species) and in Thespesia populnea. Gossypol has been shown to exhibit potent anti-proliferation ability against a range of human cancer cells, including ovarian, endometrial, colon, cervical, lung, colon, leukemia and melanoma [14, 15, 17–22, 25-33, 36]. More interestingly, gossypol also showed cytotoxic property against cell lines resistant to vinblastine, adriamycin and cisplatin . Further studies involving clinical trials showed minimal adverse effects, however the response rates of the receiving patients were low [34–36]. Hence additional studies need to be performed to explore either a new extract or a synergistic combination with an additional compound.
Studies were performed with the barks of A. pavonina in respect to their anti-inflammatory abilities . However, recent reports have also demonstrated the cytotoxic potential of the ethanolic seed extracts of A. pavonina. Ferreira et al. (2011) reported that, after 72 h of treatment with ethanolic seed extracts of A. pavonina (50 μg/mL), there was a 30.8 ± 5.2, 23.7 ± 3.2, 4.5 ± 2.4, and 1.2 ± 13.2 % proliferation inhibition for HCT-8, SF-295, MDA MB-435 and HL-60 cells respectively . However, studies on cytotoxic potential of the bark of this plant have been explored only to a minimal extent. Hence, this is the first instance where the cytotoxic ability of a decoction composed of barks of Thespesia populnea and Adenanthera pavonina is described. The decoction displayed cytotoxic effects against the HEp-2 cell line, however, the toxic doses for brine shrimp larvae are in the range 10–100 times higher in comparison to cell culture methods. The brine shrimp lethality assay has been widely used to screen toxicity and the level of toxicity of pesticides, dental materials, crude plant extracts and fractions, secondary metabolites and nanoparticles [39, 40]. Meyer (1982) has reported that extracts obtained from natural products which have LC50 ≤ 1.0 mg/mL are known to possess toxic effects . The present study shows an EC50 value of 1.96 mg/mL for brine shrimp assay, whereas for studies on anti-proliferation of cancer cells, the value ranges from 77 to 195 μg/ml proving that no such toxic effects exists on Artemia salina.. However the toxicity studies against a normal mammalian cell line is still remain to be established.
The results obtained from the present study shows that the decoction containing Adenanthera pavonina L. and Thespesia populnea L. possesses potent anti-proliferative and cytotoxic activities (Table 1). The claim by traditional healers that the decoction containing Adenanthera pavonina L. and Thespesia populnea L. is partially validated in the present study by identifying its aqueous extract to contain apoptotic activity. If some of the compounds are structurally identified and characterized, they may be candidates for further anticancer drug development.
Complementary and alternative medicine
- CO2 :
Ethidium bromide/acridine orange
Eagle’s Minimum Essential Medium
Fetal bovine serum
(3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide)
Grundy SM. Recent nutrition research: implications for foods of the future. Ann Med. 1991;23:187–93.
Hafidh RR, Abas F, Abdulamir AS, Jahanshiri F, Bakar FA, Sekawi Z. A review: Cancer research of natural products in Asia. Int J Cancer Res. 2009;5:69–82.
Perera M, Soysa S, Abeytunga DTU, Ramesh R. Antioxidant and cytotoxic properties of three traditional decoctions used for the treatment of cancer in Sri Lanka. Pharmacogn Mag. 2008;4:172–81.
Soysa P, De Silva I, Wijayabandara J. Evaluation of antioxidant and antiproliferative activity of Flueggea leucopyrus Willd (katupila). BMC Complement Altern Med. 2014;14(1):274.
Belhekar SN, Chaudhari PD, Saryawanshi JS, Mali KK, Pandhare RB. Antidiabetic and antihyperlipidemic effects of Thespesia populnea fruit pulp extracts on alloxan-induced diabetic rats. Indian J Pharm Sci. 2013;75(2):217–21.
Vasudevan M, Gunnam KK, Parle M. Antinociceptive and anti-inflammatory effects of Thespesia populnea bark extract. J Ethnopharmacol. 2007;109(2):264–70.
Saravanakumar A, Venkateshwaran K, Vanitha J, Ganesh M, Vasudevan M, Sivakumar T. Evaluation of antibacterial activity, phenol and flavonoid contents of Thespesia populnea flower extracts. Pak J Pharm Sci. 2009;22(3):282–6.
Vasudevan M, Parle M. Pharmacological actions of Thespesia populnea relevant to Alzheimer’s disease. Phytomedicine. 2006;13(9–10):677–87.
Olajide OA, Echianu CA, Adedapo ADA, Makinde JM. Anti-inflammatory studies on Adenanthera pavonina seed extract. Inflammopharmacology. 2004;12(2):196–202.
Abou Zeid AH, El-Kashoury EA, Sleem AA, Waly DA. Lipoidal Content and Anti-inflammatory Activity of Adenanthera pavonina L. Leaves J Appl Sci Res. 2012;8(1):207.
W. Radziah, M. R. Miradatul Najwa, and M. I. Nurfadilah. Basic study on antibacterial properties of Adenanthera pavonina (Saga) seed oil. ISBEIA 2011–2011 IEEE Symposium on Business, Engineering and Industrial Applications. 2011:584–587
Pandhare RB, Sangameswaran B, Mohite PB, Khanage SG. Anti-hyperglycaemic and lipid lowering potential of Adenanthera pavonina Linn. in streptozotocin induced diabetic rats. Orient Pharm Exp Med. 2012;12(3):197–203.
Mohammed RS, Abou Zeid AH, El-Kashoury EA, Sleem AA, Waly DA. A new flavonol glycoside and biological activities of Adenanthera pavonina L. leaves. Nat Prod Res. 2014;28(5):282–9.
Soysa P, Silva I. Evaluation of phytochemical composition and antioxidant capacity of a decoction containing Adenanthera pavonina L. and Thespesia populnea L. Pharmacogn Mag. 2011;7(27):193.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107–12.
Renvoizé C, Biola A, Pallardy M, Bréard J. Apoptosis: Identification of dying cells. Cell Biol Toxicol. 1998;14(2):111–20.
Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;5:12.
Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med. 1982;45(5):31–4.
Filshie J, Rubens CNJ. Complementary and alternative medicine. Anesthesiol Clin. 2006;24(1):81–111.
Boonsri S, Karalai C, Ponglimanont C, Chantrapromma S, Kanjana-opas A. Cytotoxic and antibacterial sesquiterpenes from Thespesia populnea. J Nat Prod. 2008;71(7):1173–7.
Johnson J, Gandhidasan I, Murugesan R. Cytotoxicity and superoxide anion generation by some naturally occurring quinones. Free Radic Biol Med. 1999;26(9–10):1072–8.
Masuda T, Oyama Y, Yonemori S, Takeda Y, Yamazaki Y, Mizuguchi S, et al. Flow cytometric estimation on cytotoxic activity of leaf extracts from seashore plants in subtropical Japan: Isolation, quantification and cytotoxic action of (−)- deoxypodophyllotoxin. Phyther Res. 2002;16(4):353–8.
Dodou K, Anderson RJ, Small DAP, Groundwater PW. Investigations on gossypol: past and present developments. Expert Opin Investig Drugs. 2005;14(11):1419–34.
Band V, Hoffer AP, Band H, Rhinehardt AE, Knapp RC, Matlin SA, et al. Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol Oncol. 1989;32(3):273–7.
Leblanc ML, Russo J, Kudelka AP, Smith JA. An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines. Pharmacol Res. 2002;46(6):551–5.
Coyle T, Levante S, Shetler M, Winfield J. In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines. J Neurooncol. 1994;19(1):25–35.
Tuszynski GP, Cossu G. Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res. 1984;44(2):768–71.
Jaroszewski JW, Kaplan O, Cohen JS. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies. Cancer Res. 1990;50(21):6936–43.
Shelley MD, Hartley L, Groundwater PW, Fish RG. Structure-activity studies on gossypol in tumor cell lines. Anticancer Drugs. 2000;11(3):209–16.
Benz CC, Keniry MA, Ford JM, Townsend AJ, Cox FW, Palayoor S, et al. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol Pharmacol. 1990;37(6):840–7.
Oliver CL, Miranda MB, Shangary S, Land S, Wang S, Johnson DE. (−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol Cancer Ther. 2005;4(1):23–31.
Blackstaffe L, Shelley MD, Fish RG. Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell lines. Melanoma Res. 1997;7(5):364–72.
Stein RC, Joseph AE, Matlin SA, Cunningham DC, Ford HT, Coombes RC. A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol. 1992;30(6):480–2.
Bushunow P, Reidenberg MM, Wasenko J, Winfield J, Lorenzo B, Lemke S, et al. Gossypol treatment of recurrent adult malignant gliomas. J Neurooncol. 1999;43(1):79–86.
van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K, et al. Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat. 2001;66(3):239–48.
Ara A, Arifuzzaman M, Ghosh CK, Hashem MA, Ahmad MU, Bachar SC, et al. Anti-inflammatory activity of Adenanthera pavonina L., Fabaceae, in experimental animals. Rev Bras Farmacogn. 2010;20(6):929–32.
Ferreira PMP, Farias DF, Viana MP, Souza TM, Vasconcelos IM, Soares BM, et al. Study of the antiproliferative potential of seed extracts from Northeastern Brazilian plants. An Acad Bras Cienc. 2011;83(3):1045–58.
Hamidi МR, Jovanova B, Panovska ТK. Toxicоlogical evaluation of the plant products using Brine Shrimp (Artemia salina L.) model. Maced Pharm Bull. 2014;60(1):9–18.
McLaughlin JL, Rogers LL, Anderson JE. The use of biological assays to evaluate botanicals. Drug Inf J. 1998;32(2):513–24.
We acknowledge the research grant from the National Science Foundation, Sri Lanka, grant No. RG/2005/HS 17 awarded to Professor Preethi Soysa. Authors particularly thank Dr. N. Jayathilake for providing the recipe of the decoction and Ms. Sudeepa Sugathadasa, Department of Botany, Bandaranayake Memorial Ayurveda Research Institute, Nawinna, Colombo, Sri Lanka, for the identification of the plant material.
The authors declare that they have no competing interests, financially or otherwise.
Experimental work, data analysis and drafting of the manuscript were carried out by IKSL. PS was involved with designing the project, data interpretation and revising the manuscript. Both authors read and approved the final manuscript.
About this article
Cite this article
Lindamulage, I.K.S., Soysa, P. Evaluation of anticancer properties of a decoction containing Adenanthera pavonina L. and Thespesia populnea L.. BMC Complement Altern Med 16, 70 (2016). https://doi.org/10.1186/s12906-016-1053-9
- Adenanthera pavonina
- Thespesia populnea
- Traditional decoction